WA HB1352 | 2019-2020 | Regular Session
Status
Spectrum: Moderate Partisan Bill (Democrat 5-1)
Status: Introduced on January 21 2019 - 25% progression, died in committee
Action: 2020-01-13 - Referred to Health Care & Wellness.
Pending: House Health Care and Wellness Committee
Text: Latest bill text (Comm Sub) [PDF]
Status: Introduced on January 21 2019 - 25% progression, died in committee
Action: 2020-01-13 - Referred to Health Care & Wellness.
Pending: House Health Care and Wellness Committee
Text: Latest bill text (Comm Sub) [PDF]
Summary
Compounding drugs.
Title
Compounding drugs.
Sponsors
| Rep. My-Linh Thai [D] | Rep. Paul Harris [R] | Rep. Vandana Slatter [D] | Rep. Sherry Appleton [D] |
| Rep. Laurie Jinkins [D] | Rep. Lillian Ortiz-Self [D] |
History
| Date | Chamber | Action |
|---|---|---|
| 2020-01-13 | House | Referred to Health Care & Wellness. |
| 2020-01-13 | House | Rules Committee relieved of further consideration. |
| 2020-01-13 | House | By resolution, reintroduced and retained in present status. |
| 2019-02-19 | House | Referred to Rules 2 Review. |
| 2019-02-15 | House | HCW - Majority; 1st substitute bill be substituted, do pass. |
| 2019-02-15 | House | Executive action taken in the House Committee on Health Care & Wellness at 8:00 AM. |
| 2019-02-13 | House | Executive session scheduled, but no action was taken in the House Committee on Health Care & Wellness at 1:30 PM. |
| 2019-02-06 | House | Public hearing in the House Committee on Health Care & Wellness at 1:30 PM. |
| 2019-01-21 | House | First reading, referred to Health Care & Wellness. |
Same As/Similar To
SB5663 (Crossfiled) 2020-01-13 - By resolution, reintroduced and retained in present status.
